Shopping Cart
- Remove All
- Your shopping cart is currently empty
KYN-101 is an orally active and selective aryl hydrocarbon receptor (AHR) inhibitor with anticancer activity. KYN-101 decreases CYP1A1 mRNA expression and can be used in the study of breast cancer and acute myeloid leukemia. KYN-101 is an orally active and selective aryl hydrocarbon receptor (AHR) inhibitor with anticancer activity.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $61 | In Stock | |
5 mg | $147 | In Stock | |
10 mg | $228 | In Stock | |
25 mg | $428 | In Stock | |
50 mg | $662 | In Stock | |
100 mg | $993 | In Stock |
Description | KYN-101 is an orally active and selective aryl hydrocarbon receptor (AHR) inhibitor with anticancer activity. KYN-101 decreases CYP1A1 mRNA expression and can be used in the study of breast cancer and acute myeloid leukemia. KYN-101 is an orally active and selective aryl hydrocarbon receptor (AHR) inhibitor with anticancer activity. |
In vivo | KYN-101 (10 mg/kg; once daily for 12 days; oral administration) treatment in 6-8-week-old C57BL/6J mice (B16IDO tumor-bearing mice) significantly reduced tumor growth. Additionally, the combination of KYN-101 and anti-PD-1 antibody further delayed tumor growth and extended survival in CT26 models[1]. |
Alias | KYN101, KYN 101 |
Molecular Weight | 386.43 |
Formula | C22H19FN6 |
Cas No. | 2247950-73-6 |
Storage | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 80 mg/mL (207.03 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.